2013 Hilton Head Workshop for Regenerative Medicine

2013年希尔顿头岛再生医学研讨会

基本信息

  • 批准号:
    8529819
  • 负责人:
  • 金额:
    $ 0.99万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-03-01 至 2014-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The Georgia Institute of Technology's Petit Institute for Bioengineering and Bioscience is partnering for the second time with the University of Pittsburgh's McGowan Institute for Regenerative Medicine to organize and host the 17th Annual Hilton Head Workshop for Regenerative Medicine. The Hilton Head Workshop for Regenerative Medicine is an annual conference series initiated by Georgia Tech in 1997. The conference goals are to promote discussion, advance knowledge, and foster the formation of collaborative relationships between academic researchers, clinicians, and industry leaders to advance the science and the development of patient therapies. Conference keynote speakers are considered the foremost experts in their fields, and the conference attracts both a national and international audience. With new discoveries occurring almost weekly, particularly in the area of stem cell research, forums that allow scientists, bioengineers, and clinicians to interact and learn from one another are essential to the development of collaborative research initiatives and for identifying new research directions. The 2013 conference theme is "Regenerative Medicine: Technologies Enabling Novel Therapies" and will focus on progress and challenges with regenerative medicine in clinical applications. Session topics will highlight induced pluripotent stem cells, endogenous repair mechanisms, and immunological effects of regeneration, biomaterials, and clinical applications, among others. The Hilton Head Workshop is unique in that it is kept small (less than 230 participants) to maximize interactions and networking so that true collaborations can emerge. The conference provides professional development and networking opportunities for graduate students and postdoctoral trainees that include participation in a poster presentation session, as well as plenary presentation opportunities for outstanding poster abstracts. The purpose of this proposal is to provide conference fee and travel funds for 24 students and postdoctoral trainees and six young faculties to attend the conference. The conference will be rigorously publicized to attract women and underrepresented minorities, with particular focus on historically black universities and medical schools, as well as individuals with disabilities.
描述(由申请人提供):佐治亚理工学院佩蒂特生物工程和生物科学研究所第二次与匹兹堡大学麦高恩再生医学研究所合作,组织和主办第 17 届希尔顿海德再生医学年度研讨会。希尔顿海德再生医学研讨会是佐治亚理工学院于 1997 年发起的年度系列会议。会议的目标是促进讨论、增进知识并促进学术研究人员、临床医生和行业领导者之间合作关系的形成,以推动科学和患者疗法的发展。会议主讲人被认为是各自领域最重要的专家,会议吸引了国内外的专家 观众。随着几乎每周都有新发现出现,特别是在干细胞研究领域,允许科学家、生物工程师和临床医生相互交流和学习的论坛对于合作研究计划的发展和确定新的研究方向至关重要。 2013年会议的主题是“再生医学:实现新疗法的技术”,并将重点关注再生医学在临床应用中的进展和挑战。会议主题将重点讨论诱导多能干细胞、内源性修复机制、再生的免疫效应、生物材料和临床应用等。希尔顿头岛研讨会的独特之处在于其规模较小(参与者少于 230 人),以最大限度地提高互动和网络,从而实现真正的合作。该会议为研究生和博士后实习生提供专业发展和交流的机会,包括参加海报展示会议,以及优秀海报摘要的全体会议展示机会。该提案的目的是为参加会议的 24 名学生和博士后学员以及 6 名年轻教师提供会议费和旅费。此次会议将得到严格宣传,以吸引女性和代表性不足的少数族裔,特别关注传统黑人大学和医学院以及残疾人。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ROBERT E GULDBERG其他文献

ROBERT E GULDBERG的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ROBERT E GULDBERG', 18)}}的其他基金

Immunoengineering Strategies for Musculoskeletal Trauma
肌肉骨骼创伤的免疫工程策略
  • 批准号:
    9974169
  • 财政年份:
    2020
  • 资助金额:
    $ 0.99万
  • 项目类别:
Immunoengineering Strategies for Musculoskeletal Trauma
肌肉骨骼创伤的免疫工程策略
  • 批准号:
    10155430
  • 财政年份:
    2020
  • 资助金额:
    $ 0.99万
  • 项目类别:
Immunoengineering Strategies for Musculoskeletal Trauma
肌肉骨骼创伤的免疫工程策略
  • 批准号:
    10448258
  • 财政年份:
    2020
  • 资助金额:
    $ 0.99万
  • 项目类别:
Immunoengineering Strategies for Musculoskeletal Trauma
肌肉骨骼创伤的免疫工程策略
  • 批准号:
    10612470
  • 财政年份:
    2020
  • 资助金额:
    $ 0.99万
  • 项目类别:
Mechanical Regulation of Vascular Growth and Remodeling
血管生长和重塑的机械调节
  • 批准号:
    9894763
  • 财政年份:
    2018
  • 资助金额:
    $ 0.99万
  • 项目类别:
Mechanical Regulation of Vascular Growth and Remodeling
血管生长和重塑的机械调节
  • 批准号:
    9236156
  • 财政年份:
    2016
  • 资助金额:
    $ 0.99万
  • 项目类别:
Regenerative Rehabilitation of Complex Musculoskeletal Injuries
复杂肌肉骨骼损伤的再生康复
  • 批准号:
    10570304
  • 财政年份:
    2016
  • 资助金额:
    $ 0.99万
  • 项目类别:
Regenerative Rehabilitation of Complex Musculoskeletal Injuries
复杂肌肉骨骼损伤的再生康复
  • 批准号:
    10367370
  • 财政年份:
    2016
  • 资助金额:
    $ 0.99万
  • 项目类别:
In Vivo Monitoring of Strain and Oxygen in TE Constructs Using MEMS-Based Sensors
使用基于 MEMS 的传感器对 TE 结构中的应变和氧气进行体内监测
  • 批准号:
    8970271
  • 财政年份:
    2015
  • 资助金额:
    $ 0.99万
  • 项目类别:
TERMIS-Americas 2013 Opening Conference Symposium
TERMIS-美洲2013年开幕研讨会
  • 批准号:
    8597499
  • 财政年份:
    2013
  • 资助金额:
    $ 0.99万
  • 项目类别:

相似海外基金

ADVANCED DEVELOPMENT OF LQ A LIPOSOME-BASED SAPONIN-CONTAINING ADJUVANT FOR USE IN PANSARBECOVIRUS VACCINES
用于 Pansarbecovirus 疫苗的 LQ A 脂质体含皂苷佐剂的先进开发
  • 批准号:
    10935820
  • 财政年份:
    2023
  • 资助金额:
    $ 0.99万
  • 项目类别:
ADVANCED DEVELOPMENT OF BBT-059 AS A RADIATION MEDICAL COUNTERMEASURE FOR DOSING UP TO 48H POST EXPOSURE"
BBT-059 的先进开发,作为辐射医学对策,可在暴露后 48 小时内进行给药”
  • 批准号:
    10932514
  • 财政年份:
    2023
  • 资助金额:
    $ 0.99万
  • 项目类别:
Advanced Development of a Combined Shigella-ETEC Vaccine
志贺氏菌-ETEC 联合疫苗的先进开发
  • 批准号:
    10704845
  • 财政年份:
    2023
  • 资助金额:
    $ 0.99万
  • 项目类别:
Advanced development of composite gene delivery and CAR engineering systems
复合基因递送和CAR工程系统的先进开发
  • 批准号:
    10709085
  • 财政年份:
    2023
  • 资助金额:
    $ 0.99万
  • 项目类别:
Advanced Development of Gemini-DHAP
Gemini-DHAP的高级开发
  • 批准号:
    10760050
  • 财政年份:
    2023
  • 资助金额:
    $ 0.99万
  • 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
  • 批准号:
    10409385
  • 财政年份:
    2022
  • 资助金额:
    $ 0.99万
  • 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
  • 批准号:
    10710595
  • 财政年份:
    2022
  • 资助金额:
    $ 0.99万
  • 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
  • 批准号:
    10630975
  • 财政年份:
    2022
  • 资助金额:
    $ 0.99万
  • 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE CANDIDATE FOR STAPHYLOCOCCUS AUREUS INFECTION
金黄色葡萄球菌感染候选疫苗的高级开发
  • 批准号:
    10710588
  • 财政年份:
    2022
  • 资助金额:
    $ 0.99万
  • 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
  • 批准号:
    10788051
  • 财政年份:
    2022
  • 资助金额:
    $ 0.99万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了